These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19269691)

  • 21. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early response as predictor of final remission in elderly depressed patients.
    Kok RM; van Baarsen C; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2009 Nov; 24(11):1299-303. PubMed ID: 19322797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight and obesity affect treatment response in major depression.
    Kloiber S; Ising M; Reppermund S; Horstmann S; Dose T; Majer M; Zihl J; Pfister H; Unschuld PG; Holsboer F; Lucae S
    Biol Psychiatry; 2007 Aug; 62(4):321-6. PubMed ID: 17241618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological prediction of recovery in late-onset major depression.
    Marcos T; Portella MJ; Navarro V; Gastó C; Rami L; Lázaro L; Salamero M
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):790-5. PubMed ID: 16035125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P; Legault M
    Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
    Jha MK; Wakhlu S; Dronamraju N; Minhajuddin A; Greer TL; Trivedi MH
    J Affect Disord; 2018 Jul; 234():34-37. PubMed ID: 29522941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
    Roberts RL; Joyce PR; Mulder RT; Begg EJ; Kennedy MA
    Pharmacogenomics J; 2002; 2(3):191-6. PubMed ID: 12082591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental passage of tricyclic antidepressants.
    Loughhead AM; Stowe ZN; Newport DJ; Ritchie JC; DeVane CL; Owens MJ
    Biol Psychiatry; 2006 Feb; 59(3):287-90. PubMed ID: 16271264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
    Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
    BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A surveillance study of escitalopram treatment of depressed patients.
    Anders M; Tuma I; Rösslerova H
    Expert Opin Pharmacother; 2008 Jan; 9(1):1-6. PubMed ID: 18076333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
    Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orosomucoid influences the response to antidepressants in major depressive disorder.
    Harley J; Roberts R; Joyce P; Mulder R; Luty S; Frampton C; Kennedy M
    J Psychopharmacol; 2010 Apr; 24(4):531-5. PubMed ID: 19395425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major depression predicts an increase in long-term body weight variability in young adults.
    Hasler G; Lissek S; Ajdacic V; Milos G; Gamma A; Eich D; Rössler W; Angst J
    Obes Res; 2005 Nov; 13(11):1991-8. PubMed ID: 16339131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.
    Iniesta R; Hodgson K; Stahl D; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Dobson R; Aitchison KJ; Farmer A; McGuffin P; Lewis CM; Uher R
    Sci Rep; 2018 Apr; 8(1):5530. PubMed ID: 29615645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics.
    Adeoye OM; Ferrell RE; Kirshner MA; Mulsant BH; Seligman K; Begley AE; Reynolds CF; Pollock BG
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):235-9. PubMed ID: 14653433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
    Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
    Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new role for nortriptyline in depression associated with vascular disease?
    Kunte H; Rentzsch J; Kronenberg G
    Am J Psychiatry; 2015 Feb; 172(2):201. PubMed ID: 25640936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.